Portfolio company
Mission Therapeutics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
Deep Tech
About
This company develops small-molecule drugs targeting deubiquitylating enzymes to treat patients with neurodegenerative, kidney and heart diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.